ENTITY
Bloomage Biotechnology  Lt

Bloomage Biotechnology Lt (688363 CH)

64
Analysis
Health CareChina
Bloomage Biotechnology Corporation Limited develops and manufactures medical products. The Company produces fillers, mesotherapy products, bio reactive hyaluronic acids, repair soothing skin care products, and other products. Bloomage Biotechnology supplies its products in medicine, cosmetics, food manufacturing companies, medical institutions, and other fields.
more
Refresh
17 Oct 2022 08:50

Bloomage Biotechnology (688363.CH) - Positioning and Strategic Layout Imply Strong Upside Potential

Synthetic biology/industrial chain integration help Bloomage build high moat.Synergy of multiple business improve the resilience to market...

Logo
180 Views
Share
bullishGiant Biogene
13 Oct 2022 08:46

Pre-IPO Giant Biogene - The Strength and the Concerns

Giant Biogene is in an industry that has big potential for growth in valuation. How to build long-term system advantage/core competitiveness is an...

Logo
222 Views
Share
bearishGiant Biogene
12 Oct 2022 16:21

Giant Biogene IPO: The Bear Case

The key elements of the bear case rest on a worrying performance of Collgene (the second flagship brand), an inexorable rise in S&M expenses and...

Logo
238 Views
Share
bullishGiant Biogene
11 Oct 2022 16:01

Giant Biogene IPO: The Bull Case

The key elements of the bull case rest on a large and growing addressable market, regulatory tailwinds, the core brand’s stellar performance and...

Logo
225 Views
Share
bullishGiant Biogene
11 Oct 2022 09:50

Giant Biogene Pre-IPO - PHIP Updates - Sales Growing Faster but so Have Marketing Spends

Giant Biogene aims to raise around US$500m in its Hong Kong IPO. The company is one of the leaders in the bioactive ingredient-based professional...

Logo
232 Views
Share
x